These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4644172)

  • 41. Intravenous iron: out of sight, out of mind.
    Auerbach M; Muñoz M; Macdougall IC
    Lancet Haematol; 2018 Jan; 5(1):e10-e12. PubMed ID: 29304320
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol.
    Bluemke DA; Weber TM; Rubin D; de Lange EE; Semelka R; Redvanly RD; Chezmar J; Outwater E; Carlos R; Saini S; Holland GA; Mammone JF; Brown JJ; Milestone B; Javitt MC; Jacobs P
    Radiology; 2003 Aug; 228(2):457-64. PubMed ID: 12893904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between intensive intravenous iron treatment and angina pectoris in hemodialysis patients.
    Malindretos P; Sioulis A; Avgeriou E; Michalaki A; Roma V; Grekas D
    Clin Nephrol; 2006 Oct; 66(4):312-3. PubMed ID: 17064002
    [No Abstract]   [Full Text] [Related]  

  • 44. The iron story: red smoke and magnetism?
    Wish JB
    Nephrol News Issues; 2014 Feb; 28(2):2-3. PubMed ID: 24649743
    [No Abstract]   [Full Text] [Related]  

  • 45. A case of HLA-B27 negative ankylosing spondylitis treated with methylprednisolone pulse therapy.
    Yoshida S; Motai Y; Hattori H; Yoshida H; Torikai K
    J Rheumatol; 1993 Oct; 20(10):1805-6. PubMed ID: 8295202
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous iron therapy and risk for progressive loss of kidney function in patients with chronic kidney disease.
    Mansour W; Bissram M; Rosner MH
    Nephron Clin Pract; 2011; 118(2):c189-94. PubMed ID: 21178375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A longitudinal study on an autoimmune murine model of ankylosing spondylitis.
    Bárdos T; Szabó Z; Czipri M; Vermes C; Tunyogi-Csapó M; Urban RM; Mikecz K; Glant TT
    Ann Rheum Dis; 2005 Jul; 64(7):981-7. PubMed ID: 15640265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxic reaction to intramuscular injection of iron.
    SHAFER AW; MARLOW AA
    N Engl J Med; 1959 Jan; 260(4):180. PubMed ID: 13622945
    [No Abstract]   [Full Text] [Related]  

  • 50. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population.
    Niederer R; Danesh-Meyer H
    N Z Med J; 2006 Mar; 119(1230):U1886. PubMed ID: 16532040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical features of ankylosing spondylitis--epidemiologic study].
    Jajić Z; Grazio S; Nemcić T; Jajić I
    Reumatizam; 1997; 45(2):13-8. PubMed ID: 9769723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical significance of parenteral iron compounds in gyneco-obstetric field].
    Nakajima Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1969 Jul; 21(7):719-28. PubMed ID: 5388514
    [No Abstract]   [Full Text] [Related]  

  • 53. [Osteoporosis in ankylosing spondylitis].
    Toussirot E; Wendling D
    Presse Med; 1996 Apr; 25(15):720-4. PubMed ID: 8685137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High dose intravenous iron: a note of caution.
    Kletzmayr J; Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 2002 Jun; 17(6):962-5. PubMed ID: 12032181
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired endothelial function in patients with ankylosing spondylitis.
    Sari I; Okan T; Akar S; Cece H; Altay C; Secil M; Birlik M; Onen F; Akkoc N
    Rheumatology (Oxford); 2006 Mar; 45(3):283-6. PubMed ID: 16204374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Critical remarks on the radiotherapy in ankylosing spondylitis].
    Barth G; Grebe SF; Schales F
    Verh Dtsch Ges Rheumatol; 1969; 1():149-55. PubMed ID: 5403641
    [No Abstract]   [Full Text] [Related]  

  • 58. Circumscripted pigmentations after iron injections-treatment with Q-switched laser systems.
    Raulin C; Werner S; Greve B
    Lasers Surg Med; 2001; 28(5):456-60. PubMed ID: 11413558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical presentation of ankylosing spondylitis: a case study.
    Pate D; Huslig EL
    J Manipulative Physiol Ther; 1985 Jun; 8(2):105-8. PubMed ID: 4009069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous iron does not affect the rate of decline of residual renal function in patients on peritoneal dialysis.
    Shah H; Shukla A; Krishnan A; Pliakogiannis T; Ahmad M; Bargman JM; Oreopoulos DG
    Adv Perit Dial; 2006; 22():99-103. PubMed ID: 16983949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.